Patents by Inventor Eric Prieur

Eric Prieur has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TRANSPORT CONTAINER ENVIRONMENTAL CONTROL LID
    Publication number: 20180274843
    Abstract: A transport container lid (10) is provided which includes a power source (24) providing electrical power to the container lid. An environmental control unit (20) electrically powered by the power source (24) and producing conditioned air is provided, wherein the environmental control unit (20) contains a fan (12) to distribute the conditioned air. A controller (28) in operative communication with the power source (24) and the environmental control unit (20) is provided, wherein the controller (28) adjusts the operation of the environmental control unit (20) based upon a command input.
    Type: Application
    Filed: December 2, 2016
    Publication date: September 27, 2018
    Inventors: Mary Teresa Lombardo, Eric Prieur, Renee A. Eddy, Jeffrey Allen Leshuk, Ciara Poolman
  • Fusion protein comprising the whole or part of the PP65 protein of human CMV, useable in particular for preparing a vaccine
    Patent number: 6605467
    Abstract: The invention concerns a fusion protein characterised in that it comprises at least part of the pp65 protein of the cytomegalovirus (or CMV), or a protein having at least 80% homology with the pp65 protein, in combination with at least a second peptide fragment derived from CMV. The invention also concerns a nucleotide sequence coding for such a protein, or a pharmaceutical composition containing them. It further concerns its use as medicine and a method for preparing the protein.
    Type: Grant
    Filed: July 6, 1999
    Date of Patent: August 12, 2003
    Assignee: Institut National de la Sante et de la Recherche Medicale (INSERM)
    Inventors: Eric Prieur, Jacqueline Lule, Jean-Luc Davignon, Christian Davrinche
  • FUSION PROTEIN COMPRISING THE WHOLE OR PART OF THE PP65 PROTEIN OF HUMAN CMV, USEABLE IN PARTICULAR FOR PREPARING A VACCINE
    Publication number: 20020156251
    Abstract: The invention concerns a fusion protein characterised in that it comprises at least part of the pp65 protein of the cytomegalovirus (or CMV), or a protein having at least 80% homology with the pp65 protein, in combination with at least a second peptide fragment derived from CMV. The invention also concerns a nucleotide sequence coding for such a protein, or a pharmaceutical composition containing them. It further concerns its use as medicine and a method for preparing the protein.
    Type: Application
    Filed: July 6, 1999
    Publication date: October 24, 2002
    Inventors: ERIC PRIEUR, JACQUELINE LULE, JEAN-LUC DAVIGNON
  • Method for increasing immunogenicity, product obtained and pharmaceutical compositions
    Patent number: 6342226
    Abstract: The present invention relates to a method for increasing the immunogenicity of an antigen, characterized in that the antigen is combined via stable interactions with a particulate vector, said vector containing: a non-liquid hydrophilic core, and, optionally; an outer layer of compounds chosen from the group comprising phospholipids and fatty acids. The present invention also relates to a product thereby obtained and to a pharmaceutical composition containing such product.
    Type: Grant
    Filed: December 28, 1998
    Date of Patent: January 29, 2002
    Assignee: Biovector Therapeutics, S.A.
    Inventors: Didier Betbeder, Christian Davrinche, Jean-Luc Davignon, Eric Prieur